切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2025, Vol. 21 ›› Issue (06) : 658 -664. doi: 10.3877/cma.j.issn.1673-5250.2025.06.008

论著

儿童肺炎衣原体肺炎患儿的临床特征分析
闫伦静, 张馨, 徐俊, 尹磊, 王奕涵, 花盛浩()   
  1. 苏州大学附属儿童医院检验科,苏州 215003
  • 收稿日期:2025-08-15 修回日期:2025-10-10 出版日期:2025-12-01
  • 通信作者: 花盛浩

Clinical characteristics of Chlamydia pneumoniae infection in children

Lunjing Yan, Xin Zhang, Jun Xu, Lei Yin, Yihang Wang, Shenghao Hua()   

  1. Department of Clinical Laboratory, Children′s Hospital of Soochow University, Suzhou 215003, Jiangsu Province, China
  • Received:2025-08-15 Revised:2025-10-10 Published:2025-12-01
  • Corresponding author: Shenghao Hua
  • Supported by:
    Suzhou′s Youth Initiative for the Prosperity of Science and Education in Health(KJXW2023025); Suzhou′s Applied Basic Research and Technology Innovation Project(SYW2024107)
引用本文:

闫伦静, 张馨, 徐俊, 尹磊, 王奕涵, 花盛浩. 儿童肺炎衣原体肺炎患儿的临床特征分析[J/OL]. 中华妇幼临床医学杂志(电子版), 2025, 21(06): 658-664.

Lunjing Yan, Xin Zhang, Jun Xu, Lei Yin, Yihang Wang, Shenghao Hua. Clinical characteristics of Chlamydia pneumoniae infection in children[J/OL]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2025, 21(06): 658-664.

目的

探讨肺炎衣原体(CP)感染导致儿童肺炎衣原体肺炎(CPP)患儿的临床特征。

方法

选择2023年7月至2025年4月苏州大学附属儿童医院收治的174例CPP患儿为研究对象。根据是否单纯CP感染,将其分为A组(n=96,单纯CP感染患儿)和B组(n=78,CP+其他病原体感染患儿);再根据CP感染与混合感染病原体种类将B组患儿进一步分为B1亚组(n=40,CP+混合病毒+MP感染者),B2亚组(n=25,CP+混合细菌感染者)及B3亚组(n=13,CP+混合病毒+MP+细菌感染者)。采用回顾性分析方法,比较A组和B组,以及3个亚组CPP患儿临床表现、实验室检查结果、影像学特征。本研究遵循的程序符合苏州大学附属儿童医院医学伦理委员会制定的标准,并获得该伦理委员会批准(审批号:2025CS134),并与患儿监护人签署知情同意书。

结果

①这174例CPP患儿中,单纯CP感染为96例(55.2%),混合感染为78例(44.8%);以男性(64.9%,113/174)和>6岁(90.8%,158/174)患儿为主,平均病程为14 d。所有CPP患儿均有咳嗽症状,76例(43.7%)发热,138例(79.3%)咳痰。混合感染CPP患儿中,鼻病毒(HRV)检出率最高(27/78,34.6%),其次为金黄色葡萄球菌(12/78,15.4%)。②A组患儿喘息发生率显著低于B1亚组,并且差异有统计学意义(P<0.05)。A组患儿中等热发生率显著高于B2亚组,但是高热发生率显著低于B2亚组,差异均有统计学意义(P<0.05)。A组患儿呕吐发生率显著低于B3亚组,差异亦有统计学意义(P<0.05)。③A组分别与B1亚组、B2亚组、B3亚组CCP患儿的外周血白细胞计数(WBC)、中性粒细胞百分比(NEUT%)、超敏C反应蛋白(hs-CRP)、α-羟丁酸脱氢酶(α-HBDH)、丙氨酸转移酶(ALT)及肌酸激酶同工酶MB(CK-MB)水平等比较,差异均无统计学意义(P>0.05)。④影像学检查结果显示,这174例CPP患儿中,单肺受累占比较多(71.8%,125/174),右肺下叶为最常见受累部位(19.5%,34/174)。

结论

儿童CPP混合感染发生率高,年龄越小越易合并感染,临床症状更重,对于CPP患儿应积极行病原学检测,及时对其采取针对性干预措施。

Objective

To analyze the clinical features of Chlamydia pneumoniae pneumonia in children (CPP).

Methods

A total of 174 children with CPP admitted to the Suzhou University Affiliated Children′s Hospital from July 2023 to April 2025 were selected as research subjects. Based on the type of infection, they were divided into two groups, group A (n=96) and group B (n=78). The group B was further categorized into three subgroups according to the types of pathogens: subgroup B1 (n=40, mixed viral/mycoplasma pneumoniae infections), subgroup B2 (n=25, mixed bacterial infections), and subgroup B3 (n=13, mixed viral/mycoplasma pneumoniae and bacterial infections). The clinical manifestations, laboratory test results, and imaging characteristics were compared retrospectively. The study followed the standards set by the Medical Ethics Committee of the Suzhou University Affiliated Children′s Hospital and got the committee′s approval (Approval No. 2025CS134), and informed consent from the children′s guardians were obtained.

Results

①Among 174 children with CPP, 96 cases (55.2%) had isolated CP infection, while 78 cases (44.8%) had mixed infections; the majority were male (64.9%, 113/174) and over 6 years old (90.8%, 158/174), averaging 14 days of illness. All children had cough symptoms, 76 cases (43.7%) had fever, and 138 cases (79.3%) had sputum production. Among children with mixed infections, rhinovirus (HRV) had the highest detection rate (27/78, 34.6%), followed by Staphylococcus aureus (12/78, 15.4%). ②The incidence of wheezing in group A was significantly lower than that in subgroup B1, with the difference reaching statistical significance (P<0.05). In group A, the incidence of moderate fever was significantly higher, whereas the incidence of high fever was significantly lower than that in subgroup B2, and both differences were statistically significant (P<0.05). In addition, the incidence of vomiting in group A was significantly lower than that in subgroup B3, and the difference was also statistically significant (P<0.05). ③Comparisons of white blood cell count (WBC), neutrophil percentage (NEUT%), hs-CRP, alpha-hydroxybutyrate dehydrogenase(α-HBDH), alanine aminotransferase (ALT), and creatine kinase-MB isoenzyme (CK-MB) levels between group A and groups B1, B2, and B3 showed no significant differences (P>0.05). ④Imaging examination results showed that unilateral lung involvement was more common (71.8%, 125/174), with the right lower lobe being the most commonly affected area (19.5%, 34/174), and lesions involving ≥2 lung lobes were observed in 74 cases (42.5%).

Conclusions

The incidence of mixed infections in children with CPP is high. The younger they are, the more likely they are to have mixed infections, which come with more severe symptoms. For children with CPP, we should actively test for pathogens to quickly identify mixed infections and offer targeted treatments.

表1 B组78例CPP患儿的病原体占比比较[例数(%)]
表2 A组与B组CPP患儿的年龄比较[岁,M(Q1Q3)]
表3 A组与B组,B1、2、3亚组CPP患儿的临床症状发生率比较[例数(%)]
组别 例数 发热 喉间痰响 干咳 喘息 鼻塞
低热 中热 高热
A组 96 10(10.4) 23(24.0) 8(8.3) 80(83.3) 16(16.7) 3(3.1) 36(37.5)
B组 78 3(3.9) 19(24.4) 13(16.7) 60(76.9) 18(23.1) 8(10.3) 24(30.8)
B1亚组 40 2(5.0) 14(35.0) 4(10.0) 28(70.0) 12(30.0) 5(12.5) 10(25.0)
B2亚组 25 1(4.0) 1(4.0) 6(24.0) 22(88.0) 3(12.0) 2(8.0) 10(40.0)
B3亚组 13 0(0) 4(30.8) 3(23.1) 10(76.9) 3(23.1) 1(7.7) 4(30.8)
A组vs B组总体比较(χ2值/P值)   2.69/0.101 0.01/0.951 2.82/0.093 1.13/0.289 1.13/0.289 3.7/0.055 0.86/0.353
A组vs B1亚组(χ2值/P值)   1.03/0.310 1.74/0.187 0.10/0.755 3.07/0.080 3.07/0.080 4.48/0.034 1.97/0.160
A组vs B2亚组(χ2值/P值)   0.99/0.321 4.97/0.026 4.76/0.029 0.33/0.568 0.33/0.568 1.19/0.275 0.05/0.819
A组vs B3亚组(χ2值/P值)   1.49/0.222 0.29/0.593 3.24/0.072 0.33/0.568 0.33/0.568 0.68/0.411 0.22/0.637
组别 例数 流涕 呕吐 扁桃体肿大 肺湿啰音 肺干啰音 肺痰鸣音 肺喘鸣音
A组 96 37(38.5) 11(11.5) 44(45.8) 25(26.0) 1(1.0) 10(10.4) 5(5.2)
B组 78 27(34.6) 14(17.9) 32(41.0) 26(33.3) 1(1.3) 8(10.3) 7(9.0)
B1亚组 40 9(22.5) 5(12.5) 17(42.5) 14(35.0) 0(0) 4(10.0) 5(12.5)
B2亚组 25 11(44.0) 4(16.0) 8(32.0) 6(24.0) 0(0) 2(8.0) 1(4.0)
B3亚组 13 7(53.9) 5(38.6) 7(53.9) 6(46.2) 1(7.7) 2(15.4) 1(7.7)
A组vs B组总体比较(χ2值/P值)   0.29/0.593 1.47/0.225 0.41/0.525 1.12/0.293 0.02/0.882 0.01/0.973 0.95/0.335
A组vs B1亚组(χ2值/P值)   3.25/0.072 0.03/0.864 0.13/0.722 1.11/0.293 0.42/0.517 0.01/0.942 2.20/0.138
A组vs B2亚组(χ2值/P值)   0.25/0.619 0.38/0.539 1.55/0.213 0.04/0.835 0.26/0.608 0.13/0.719 0.06/0.804
A组vs B3亚组(χ2值/P值)   1.11/0.291 6.67/0.010 0.31/0.587 2.28/0.131 2.81/0.094 0.29/0.591 0.14/0.713
图1 A组与B1、2、3亚组CPP患儿实验室检查指标及病程比较(图1A:外周血WBC;图1B:NEUT%;图1C:hs-CRP;图1D:α-HBDH;图1E:ALT;图1F:CK-MB;图1G:病程)注:A组为单纯CP感染患儿,B1、2、3亚组分别为CP+病毒+MP感染患儿,CP+细菌感染患儿及CP+病毒+MP+细菌感染患儿。CPP为肺炎衣原体肺炎,CP为肺炎衣原体,MP为肺炎支原体。WBC为白细胞计数,NEUT%为中性粒细胞百分比,hs-CRP为超敏C反应蛋白,α-HBDH为α-羟丁酸脱氢酶,ALT为氨酸转移酶,CK-MB为肌酸激酶同工酶MB。ns表示差异无统计学意义(P>0.05)
表4 本研究174例CPP患儿肺部影像学检查结果比较[例数(%)]
[1]
Kurz H, Göpfrich H, Wabnegger L, et al. Role of Chlamydophila pneumoniae in children hospitalized for community-acquired pneumonia in Vienna, Austria [J]. Pediatr Pulmonol, 2009, 44(9): 873-876. DOI: 10.1002/ppul.21059.
[2]
沈娟,陈宇,沈玉凤,等. 肺炎支原体肺炎儿童的诊治研究现状[J/OL]. 中华妇幼临床医学杂志(电子版)202319(3):273-277. DOI:10.3877/cma.j.issn.1673-5250.2023.03.005.
[3]
Li X, Ma J, Li Y, et al. One-year epidemiological patterns of respiratory pathogens across age, gender, and seasons in Chengdu during the post-COVID era [J]. Sci Rep, 2025, 15(1): 357. DOI: 10.1038/s41598-024-84586-8.
[4]
Brouard J, Freymuth F, Toutain F, et al. Role of viral infections and Chlamydia pneumoniae and Mycoplasma pneumoniae infections in asthma in infants and young children. Epidemiologic study of 118 children [J]. Arch Pediatr, 2002, 9(Suppl 3): 365s-371s. DOI: 10.1016/s0929-693x(02)00145-8.
[5]
Tagini F, Opota O, Greub G. Chlamydia pneumoniae upsurge at tertiary hospital, Lausanne, Switzerland [J]. Emerg Infect Dis, 2024, 30(4): 810-812. DOI: 10.3201/eid3004.231610.
[6]
Han HY, Moon JU, Rhim JW, et al. Surge of Chlamydia pneumoniae pneumonia in children hospitalized with community-acquired pneumonia at a single center in Korea in 2016 [J]. J Infect Chemother, 2023, 29(5): 453-457. DOI: 10.1016/j.jiac.2023.01.012.
[7]
Tian Q, Xin-Cheng Q, Yamin S, et al. Surge in Chlamydia pneumoniae infections in China: insights from 2022 to 2024 [J]. Emerg Microbes Infect, 202514(1): 2552719. DOI: 10.1080/22221751.2025.2552719.
[8]
Huang Y, Chen Y, Liu M, et al. Comparative analysis of Chlamydia pneumoniae pneumonia (CPP) and Mycoplasma pneumoniae pneumonia in children and risk factors of severe CPP [J]. BMC Infect Dis, 2025, 25(1): 993. DOI: 10.1186/s12879-025-11405-4.
[9]
De Francesco MA, Poiesi C, Gargiulo F, et al. Co-infection of Chlamydia pneumoniae and Mycoplasma pneumoniae with SARS-CoV-2 is associated with more severe features [J]. J Infect, 2021, 82(4): e4-e7. DOI: 10.1016/j.jinf.2021.01.009.
[10]
温潇慧,李惠民,张晓艳,等. 儿童肺炎衣原体肺炎10例临床特征分析[J].中华儿科杂志2025, 63(4): 362-366. DOI: 10.3760/cma.j.cn112140-20241106-00797.
[11]
程永婷,贾晓晖,马良,等. 肺炎衣原体Taqman探针实时荧光定量PCR检测法 [J]. 临床检验杂志2016, 34(5): 343-346. DOI: 10.13602/j.cnki.jcls.2016.05.08.
[12]
Grayston JT. Chlamydia pneumoniae, strain TWAR [J]. Chest, 1989, 95(3): 664-669. DOI: 10.1378/chest.95.3.664.
[13]
Di Pietro M, Filardo S, Romano S, et al. Chlamydia trachomatis and Chlamydia pneumoniae interaction with the host: latest advances and future prospective [J]. Microorganisms, 2019, 7(5): 140. DOI: 10.3390/microorganisms7050140.
[14]
Edouard S, Attamna R, Million M, et al. Significant rise of Chlamydia pneumoniae infection in 2024 in Marseille, France [J]. Int J Infect Dis, 2025, 155: 107897. DOI: 10.1016/j.ijid.2025.107897.
[15]
杨德华,王颖硕. 杭州地区儿童肺炎衣原体感染流行趋势及临床特征[J].中国临床新医学2024, 17(11): 1210-1214. DOI: 10.3969/j.issn.1674-3806.2024.11.04.
[16]
Boutin S, Krumbholz A, Kramer TS, et al. Sharp increase in Chlamydia pneumoniae infections in 2024 in Germany [J]. Eur J Clin Microbiol Infect Dis, 2025. DOI: 10.1007/s10096-025-05244-z. [Epub ahead of print]
[17]
Vieyra JM, De Colsa Ranero A, Reyes DP, et al. Chlamydophila pneumoniae-associated community-acquired pneumonia in paediatric patients of a tertiary care hospital in Mexico: molecular diagnostic and clinical insights [J]. Sci Rep, 2023, 13(1): 21477. DOI: 10.1038/s41598-023-48701-5.
[18]
Thom DH, Grayston JT. Infections with Chlamydia pneumoniae strain TWAR [J]. Clin Chest Med, 1991, 12(2): 245-256.
[19]
Almirall J, Morató I, Riera F, et al. Incidence of community-acquired pneumonia and Chlamydia pneumoniae infection: a prospective multicentre study [J]. Eur Respir J, 1993, 6(1): 14-18.
[20]
黄文娣,赵玉娟,陈璐. 新生儿肺炎衣原体肺炎46例临床特征 [J].中华实用儿科临床杂志201934(22): 1740-1742. DOI: 10.3760/cma.j.issn.2095-428X.2019.22.015.
[1] 杨荣华. 基于细菌生物膜对难愈性创面的诊治[J/OL]. 中华损伤与修复杂志(电子版), 2026, 21(02): 160-160.
[2] 罗旭芳, 王艳子, 滕红娜, 赵德莉, 袁丽, 靳思雨, 官浩. 基于时机理论对重度烧伤患儿照护者照护体验的质性研究[J/OL]. 中华损伤与修复杂志(电子版), 2026, 21(01): 40-46.
[3] 杜东莲, 史志伟, 姚洁, 张树敏, 代卫斌. 基于CT影像组学和临床特征预测单发肺结节生长的临床意义[J/OL]. 中华肺部疾病杂志(电子版), 2026, 19(01): 56-61.
[4] 郑文灏, 申锦龙, 张红军, 顾兴. 205例非结核分枝杆菌肺病的性别特征性分析[J/OL]. 中华肺部疾病杂志(电子版), 2026, 19(01): 100-105.
[5] 胡海贇, 惠舟奇, 王春, 张婷, 李晓露, 李丹, 张玲玲, 沈爱珠, 张静佳, 高欢欢. 39 025例上海儿童呼吸道病原体感染及流行病学特征分析[J/OL]. 中华肺部疾病杂志(电子版), 2026, 19(01): 117-123.
[6] 陈荣荣, 秦二云, 王妮妮, 张青, 冯契靓, 刘明, 伍健, 赵云峰, 张诚实. EB病毒相关性肺淋巴瘤样肉芽肿病合并噬血细胞综合征一例并文献复习[J/OL]. 中华肺部疾病杂志(电子版), 2026, 19(01): 145-150.
[7] 叶玉娇, 李雅雯, 陈茂娴, 唐甜甜, 黄金钰, 邱秀燕. 腹部结核并发肺部感染21例临床特征分析[J/OL]. 中华肺部疾病杂志(电子版), 2026, 19(01): 164-167.
[8] 麦吾兰江·麦麦提, 阿力娅·图拉丁, 吐尔洪江·吐逊. ABO血型不相容肝移植免疫抑制策略[J/OL]. 中华肝脏外科手术学电子杂志, 2026, 15(02): 152-159.
[9] 陈赛文, 吴青杰, 林昱东, 张思成. 超声引导下闭合复位克氏针固定与切开复位克氏针固定治疗儿童肱骨内上髁骨折的疗效比较[J/OL]. 中华肩肘外科电子杂志, 2026, 14(01): 38-44.
[10] 王辉, 孙咏琪. 儿童遗传性肾脏病再认识[J/OL]. 中华肾病研究电子杂志, 2026, 15(01): 8-14.
[11] 郎伟宁, 郝旭东, 张培霞. 布拉氏酵母菌散联合蒙脱石散治疗诺如病毒肠炎的疗效及对肠道微生态的影响[J/OL]. 中华消化病与影像杂志(电子版), 2026, 16(02): 185-189.
[12] 孙太鹏, 袁勇贵. 儿童青少年精神卫生服务的现状与展望[J/OL]. 中华临床医师杂志(电子版), 2025, 19(11): 805-808.
[13] 洪素, 况利. ICD-11 CDDR框架下的实践参考:儿童青少年心境障碍[J/OL]. 中华临床医师杂志(电子版), 2025, 19(11): 814-817.
[14] 陈妍, 陈珏. ICD-11 CDDR框架下的实践参考:儿童青少年心身疾病[J/OL]. 中华临床医师杂志(电子版), 2025, 19(11): 818-822.
[15] 高桃桃, 刘立福, 陈茵桐, 周颖璇, 邓小燕, 梁晓丽. 流行性感冒病毒继发细菌感染流行病学和致病机制研究进展[J/OL]. 中华临床实验室管理电子杂志, 2026, 14(01): 74-80.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?